Rvl Pharmaceuticals Plc
RVLPQ
Revenue
8.26M
▼-574.00k▼-6.50%
3 Months ChangeAssets
85.40M
▼-25.70M▼-23.13%
3 Months ChangeLiabilities
69.08M
▼-2.03M▼-2.85%
3 Months ChangeFree Cash Flow
-7.12M
▲6.18M▲46.46%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-02-13
Form 8-K
ID: 0001104659-24-019866
2024-01-17
Form 8-K
ID: 0001104659-24-004463
2023-12-20
Form 8-K
ID: 0001104659-23-127735
2023-11-27
Form 8-K
ID: 0001104659-23-121234
2023-11-06
Form 8-K
ID: 0001104659-23-114741
2023-10-20
Form 8-K
ID: 0001104659-23-110536
2023-10-13
Form 8-K
ID: 0001104659-23-109105
2023-09-29
Form 8-K
ID: 0001104659-23-105302
2023-09-22
Form 8-K
ID: 0001104659-23-103183
2023-09-05
Form 8-K
ID: 0001104659-23-098234